COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis

Jineta Banerjee, Jan M. Friedman, Laura J. Klesse, Kaleb Yohay, Children’s Tumor Foundation Clinical Care Advisory Board, Justin T Jordan, Scott Plotkin, Robert J Allaway, Jaishri Blakeley
doi: https://doi.org/10.1101/2022.03.31.22273208

Data Availability

All data analyzed in this study are available online at the N3C Data Enclave (https://covid.cd2h.org/enclave). Access to data requires approval from the N3C data access committee. No new data was produced in this study. All the R code used for the analyses in this study is available on Github (https://github.com/jaybee84/NF-COVID-response).

https://covid.cd2h.org/enclave

Back to top
Posted April 01, 2022.
Download PDF

Supplementary Material

Data/Code
Email
COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis
Jineta Banerjee, Jan M. Friedman, Laura J. Klesse, Kaleb Yohay, Children’s Tumor Foundation Clinical Care Advisory Board, Justin T Jordan, Scott Plotkin, Robert J Allaway, Jaishri Blakeley
medRxiv 2022.03.31.22273208; doi: https://doi.org/10.1101/2022.03.31.22273208
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area